Company page
Taigen Biopharmaceuticals Holdings Limited
Taigen Biopharmaceuticals Holdings Limited, listed under the ticker 4157, operates in the Taiwanese market. The company has a market capitalization of approximately NT$203.8 million. Taigen focuses on the development and commercialization of innovative biopharmaceutical products.
- Ticker
- 4157:TPEX
- Asset type
- Stock
- Market cap
- $203.8M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- TPEX
- Currency
- TWD